metricas
covid
Buscar en
Gastroenterología y Hepatología (English Edition)
Toda la web
Inicio Gastroenterología y Hepatología (English Edition) Prognostic risk factors in 113 patients undergoing cephalic duodenopancreatectom...
Journal Information
Vol. 47. Issue 5.
Pages 448-456 (May 2024)
Share
Share
Download PDF
More article options
Vol. 47. Issue 5.
Pages 448-456 (May 2024)
Original article
Prognostic risk factors in 113 patients undergoing cephalic duodenopancreatectomy for distal cholangiocarcinoma
Factores de mal pronóstico en 113 pacientes sometidos a duodenopancreatectomía cefálica por colangiocarcinoma distal
Juli Busquetsa,b,c,,
Corresponding author
jbusquets@bellvitgehospital.cat

Corresponding author.
, Luís Secanellaa,c,d,, Paula Cifrea,b, María Sorribasa,c, Teresa Serranoe, Laura Martínez-Carnicerof, David Leivaf, Berta Laquenteg, Silvia Salordc,h, Nuria Peláeza,c, Juan Fabregata,c
a Unitat de Cirurgia Hepatobiliopancreàtica, Servei de Cirurgia General i Digestiva, Hospital Universitari de Bellvitge, Barcelona, Spain
b Departament de Ciències Clíniques, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain
c Research Group of Hepato-biliary and Pancreatic Diseases, Institut d’Investigació Biomèdica de Bellvitge - IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain
d Departament d’Infermeria Fonamental i Medicoquirúrgica, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain
e Servei de Anatomia Patològica, Hospital Universitari de Bellvitge, Barcelona, Spain
f Servei de Radiodiagnòstic, Hospital Universitari de Bellvitge, Barcelona, Spain
g Servei d’Oncologia Mèdica, Instituto Catalán de Oncología, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain
h Servei de Gastroenterologia, Hospital Universitari de Bellvitge, Barcelona, Spain
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (3)
Show moreShow less
Tables (3)
Table 1. Descriptive analysis of patients undergoing pancreaticoduodenectomy for distal cholangiocarcinoma, 1990-2021.
Table 2. Analysis of surgical resection specimens from pancreaticoduodenectomy for distal cholangiocarcinoma.
Table 3. Long-term mortality risk factors. Univariate and multivariate logistic regression (forward conditional).
Show moreShow less
Abstract
Introduction

Distal cholangiocarcinoma is a malignant epithelial neoplasia that affects the extrahepatic bile ducts, below the cystic duct. No relevant relationship between perioperative factors and worse long-term outcome has been proved.

Objective

To analyze the risk factors for mortality and long-term recurrence of distal cholangiocarcinoma in resected patients.

Material and methods

A single-center prospective database of patients operated on for distal cholangiocarcinoma between 1990 and 2021 was analyzed in order to investigate mortality and recurrence factors.

Results

113 patients have undergone surgery, with mean actuarial survival of 100.2 (76–124) months after resection. The bivariate study did not show differences between patients depending on age or preoperative variables studied. When multivariate analysis was performed, the presence of affected adenopathy was a risk factor for long-term mortality. The presence of affected lymph nodes, tumor recurrence, and biliary fistula during the postoperative period implied worse actuarial survival when comparing the Kaplan-Meier curves.

Conclusions

The presence of affected lymph nodes influence the prognosis of the disease. The occurrence of biliary fistula during postoperative cholangiocarcinoma distal could aggravate long-term outcomes, a finding that should be reaffirmed in future studies.

Keywords:
Cholangiocarcinoma
Pancreatoduodenectomy
Postoperative survival
Postoperative risk factors
Resumen
Introducción

El colangiocarcinoma distal es una neoplasia epitelial maligna que afecta a los conductos biliares extrahepáticos, per debajo del conducto cístico. Existe poca evidencia sobre la relación entre factores perioperatorios y peor evolución a largo plazo tras la resección quirúrgica.

Objetivo

Analizar los factores de riesgo de mortalidad y recidiva a largo plazo del colangiocarcinoma distal de los pacientes resecados.

Material y métodos

Se ha analizado una base de datos prospectiva unicéntrica de pacientes intervenidos por colangiocarcinoma distal entre 1990 y 2021 con la finalidad de investigar los factores de mortalidad y recidiva.

Resultados

Se han intervenido 113 pacientes, con una supervivencia actuarial media de 100.2 (76–124) meses tras la resección. El estudio bivariante no evidenció diferencias entre los pacientes dependiendo de la edad o variables preoperatorias estudiadas. La presencia de adenopatías afectadas fue un factor de riesgo de mortalidad a largo plazo en el estudio multivariante. La presencia de adenopatías afectadas, la recidiva tumoral, y la fístula biliar durante el postoperatorio implicaron peor supervivencia actuarial al comparar las curvas de Kaplan- Meier.

Conclusiones

La presencia de adenopatías afectadas influyen en el pronóstico de la enfermedad. La aparición de fístula biliar durante el postoperatorio del colangiocarcinoma distal podría agravar los resultados a largo plazo, hallazgo que debe ser reafirmado en futuros estudios.

Palabras clave:
Colangiocarcinoma
Duodenopancreatectomía cefálica
Supervivencia a largo plazo
Factores de riesgo

Article

These are the options to access the full texts of the publication Gastroenterología y Hepatología (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Gastroenterología y Hepatología (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos